We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Turns to Advisory Panel for Comment on ECT Class
FDA Turns to Advisory Panel for Comment on ECT Class
December 3, 2010
The FDA is asking an advisory committee to weigh in on whether electroconvulsive therapy (ECT) devices should be downgraded to Class II.